|
Editorial
|
|
Arguments for the ethical permissibility of transgenic xenografting
|
633
|
|
Katrina A Bramstedt
|
| Full Article PDF
|
 |
|
|
Meeting report
|
|
Liposome advances: progress in drug and vaccine delivery, Fourth International CDDR Conference, 13–17 December 1999
|
635
|
|
N Brown
|
| Full Article PDF
|
| |
|
|
Viral transfer technology
|
|
Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients
|
637
|
|
Y Stallwood, KD Fisher, PH Gallimore & V Mautner
|
| Abstract Full Article PDF
|
| |
|
Selective in vivo transfection of murine biliary epithelia using polycation-enhanced adenovirus
|
644
|
|
TR McKay, LJ MacVinish, B Carpenter, M Themis, S Jezzard, R Goldin, A Pavirani, ME Hickman, AW Cuthbert & C Coutelle
|
| Abstract Full Article PDF
|
| |
|
Long-term silencing of retroviral vectors is resistant to reversal by trichostatin A and 5-azacytidine
|
653
|
|
JM McInerney, JR Nawrocki & CH Lowrey
|
| Abstract Full Article PDF
|
| |
|
Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vector
|
664
|
|
C Hiller, S Wittmann, S Slavin & H Fickenscher
|
| Abstract Full Article PDF
|
| |
|
Gene transfer to adult human lung tissue ex vivo
|
675
|
|
S McBride, D Rannie & DJ Harrison
|
| Abstract Full Article PDF
|
| |
|
Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced cytotoxicity of a truncated HSV1-TK
|
679
|
|
C Cowsill, TD Southgate, G Morrissey, RA Dewey, AE Morelli, TC Maleniak, Z Forrest, D Klatzmann, GWG Wilkinson, PR Löwenstein & MG Castro
|
| Abstract Full Article PDF
|
| |
|
|
Acquired diseases
|
|
Glioma/glioblastoma-specific adenoviral gene expression using the nestin gene regulator
|
686
|
|
H Kurihara, A Zama, M Tamura, J Takeda, T Sasaki & T Takeuchi
|
| Abstract Full Article PDF
|
| |
|
8 Br-cAMP enhances both humoral and cell-mediated immune responses induced by an HIV-1 DNA vaccine
|
694
|
|
H Arai, K-Q Xin, K Hamajima, Y Lu, S Watabe, T Takahashi, S Toda, K Okuda, I Kudoh, M Suzuki & K Okuda
|
| Abstract Full Article PDF
|
| |
|
DNA vaccination with full-length or truncated Neu induces protective immunity against the development of spontaneous mammary tumors in HER-2/neu transgenic mice
|
703
|
|
A Amici, A Smorlesi, G Noce, G Santoni, P Cappelletti, L Capparuccia, R Coppari, R Lucciarini, C Petrelli & M Provinciali
|
| Abstract Full Article PDF
|
| |
|
|
Cell-based therapy
|
Induction of potent antitumor response by vaccination with tumor lysate-pulsed macrophages engineered to secrete macrophage colony-stimulating factor and interferon-
|
707
|
|
H Lei, DW Ju, Y Yu, Q Tao, G Chen, S Gu, H Hamada & X Cao
|
| Abstract Full Article PDF
|
| |
|
Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta
|
714
|
|
A Annenkov & Y Chernajovsky
|
| Abstract Full Article PDF
|
| |
| |
| |
